Company / Interest Expense per Share
FATE THERAPEUTICS INC Interest Expense per Share History
FY2016-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.02
FY2021
5-year range
$0.02 / $0.02
FY2017-FY2021
Trend
-10.8%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Interest Expense per Share has fluctuated over the past 6 years, ranging from $0.02 in FY2016 to $0.05 in FY2017.
Based on SEC 10-K filings.
0.02 in FY2021 with a 5-year CAGR of +0.9%.
Remained stable around $0.02 over the past 2 years.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -13.7%
- 5-Year CAGR
- +0.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2021, interest expense per share decreased 10.8% year-over-year.
- Peak interest expense per share was recorded in FY2017.
- Lowest interest expense per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 632.81 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $0.02 | -10.8% |
| FY2020 | $0.02 | +14.3% |
| FY2019 | $0.02 | -37.0% |
| FY2018 | $0.03 | -42.0% |
| FY2017 | $0.05 | +180.6% |
| FY2016 | $0.02 | -50.6% |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026